| 1 |
Ropper AH. Unusual clinical variants and signs in Guillain-Barre syndrome. Arch Neurol 1986;43:1150-1152.
DOI
|
| 2 |
Kim JK. Anti-GQ1b antibody syndrome; is the another name of Miller Fisher syndrome or advent of a new syndrome? J Korean Neurol Assoc 2009;27:307-312.
|
| 3 |
Nagashima T, Koga M, Odaka M, Hirata K, Yuki N. Continuous spectrum of pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. Arch Neurol 2007;64:1519-1523.
DOI
|
| 4 |
Yang TI, Park YE, Kim JK, Cha SY, Kim TH, et al. Guillain- Barre syndrome with antibody to ganglioside GT1a. J Korean Neurol Assoc 2010;28:291-294.
|
| 5 |
Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller-Fisher syndrome. Neurol 2001;56:1104-1106.
DOI
|
| 6 |
Kim S, Lee JH, Jo JW, Park KP, Kim DS. Unilateral facial palsy in acute ophthalmoplegia associated with Anti-GQ1b antibody. Korean J Clin Neurophysiol 2011;13:111-113.
|
| 7 |
Van Koningsveld R, Schmitz PIM, van der Meche FGA, Visser LH, Meulstee J, van Doorn PA, et al. Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barre syndrome: randomised trial. Lancet 2004;363:192-196.
DOI
|
webmaster
